Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BOSS ZHIPIN-W
02076
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.66%89.45B | 8.03%77.33B | 10.18%19.14B | 8.13%20.48B | 8.12%19.11B | 5.73%18.6B | 3.45%71.58B | 2.89%17.37B | 4.48%18.94B | 1.92%17.67B |
| Cost of revenue | 13.87%67.73B | 8.60%59.48B | 10.59%14.72B | 8.92%15.74B | 8.71%14.71B | 6.19%14.3B | 3.57%54.77B | 3.06%13.31B | 4.39%14.45B | 2.25%13.53B |
| Gross profit | 21.63%21.72B | 6.17%17.85B | 8.80%4.42B | 5.58%4.74B | 6.19%4.4B | 4.21%4.3B | 3.07%16.82B | 2.33%4.06B | 4.80%4.49B | 0.85%4.14B |
| Operating expense | 24.47%19.45B | 2.94%15.63B | 5.81%4B | 1.98%3.92B | 2.20%3.9B | 1.78%3.81B | 3.72%15.18B | 3.18%3.78B | 4.16%3.84B | 1.87%3.81B |
| Staff costs | 9.32%5.82B | 2.84%5.32B | ---- | ---- | ---- | ---- | -0.56%5.18B | ---- | ---- | ---- |
| Selling and administrative expenses | 144.26%4.2B | -12.13%1.72B | ---- | ---- | ---- | ---- | 24.41%1.96B | ---- | ---- | ---- |
| -Selling and marketing expense | 411.47%2.72B | -1.01%531.34M | ---- | ---- | ---- | ---- | -6.09%536.77M | ---- | ---- | ---- |
| -General and administrative expense | 24.72%1.48B | -16.34%1.19B | ---- | ---- | ---- | ---- | 41.83%1.42B | ---- | ---- | ---- |
| Rent and land expenses | 4.67%2.13B | 0.29%2.03B | ---- | ---- | ---- | ---- | 0.09%2.03B | ---- | ---- | ---- |
| Other operating expenses | 11.48%7.3B | 8.81%6.55B | ---- | ---- | ---- | ---- | 3.24%6.02B | ---- | ---- | ---- |
| Operating profit | 1.74%2.27B | 36.19%2.23B | 49.58%415.69M | 26.82%824.91M | 52.63%501.12M | 28.22%486.13M | -2.65%1.64B | -7.98%277.91M | 8.73%650.45M | -9.64%328.33M |
| Net non-operating interest income (expenses) | -73.02%-37.99M | -15.28%-21.96M | -40.91%-6.62M | -15.75%-5.85M | -5.68%-5.12M | 1.84%-4.37M | -5.23%-19.05M | -7.51%-4.7M | -13.42%-5.06M | -3.28%-4.84M |
| Non-operating interest income | 624.62%471K | 160.00%65K | 525.00%50K | --0 | 300.00%12K | -50.00%3K | 78.57%25K | 166.67%8K | 700.00%8K | -66.67%3K |
| Non-operating interest expense | 74.65%38.46M | 15.47%22.02M | 41.73%6.67M | 15.56%5.85M | 5.86%5.13M | -1.91%4.37M | 5.29%19.07M | 7.62%4.7M | 13.57%5.06M | 3.15%4.85M |
| Net investment income | 45.07%27.31M | 25.90%18.82M | 0.00%2.82M | 51.73%7.73M | 0 | 17.58%8.28M | 8.07%14.95M | 10.00%2.82M | 15.57%5.09M | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -30.63%10.48M | 10.48M | 1,033.78%15.1M | 0 | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 39.29%-170.77M | -3,037.66%-281.28M | -1,100.77%-281.28M | 0 | 112.16%9.58M | -23.43M | 0 | 0 | ||
| Less:Other special charges | 181.39%9.42M | 84.62%-11.57M | ---- | ---- | ---- | ---- | ---75.28M | ---42.28M | --0 | --0 |
| Less:Write off | -44.90%161.35M | 345.73%292.86M | ---- | ---- | ---- | ---- | -16.58%65.7M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -20.08%119.6M | 23.93%149.65M | 52.27%39.76M | 8.04%37.89M | 10.12%34.68M | 32.92%37.31M | -12.71%120.75M | -30.31%26.11M | -5.22%35.07M | -4.06%31.5M |
| Income before tax | 4.81%2.2B | 18.37%2.1B | -35.11%180.85M | 23.41%864.68M | 49.50%530.68M | 19.10%527.35M | 2.31%1.78B | 7.65%278.71M | 10.08%700.66M | -9.33%354.98M |
| Income tax | 8.99%707.68M | 10.06%649.31M | -64.99%34.99M | 21.03%272.95M | 45.06%176.19M | 15.47%165.18M | 45.33%589.98M | 129.00%99.93M | 8.03%225.53M | 803.13%121.46M |
| Net income | 2.95%1.5B | 22.50%1.45B | -18.42%145.86M | 24.54%591.73M | 51.81%354.5M | 20.83%362.16M | -10.81%1.19B | -16.95%178.78M | 11.08%475.14M | -38.23%233.52M |
| Net income continuous operations | 2.95%1.5B | 22.50%1.45B | -18.42%145.86M | 24.54%591.73M | 51.81%354.5M | 20.83%362.16M | -10.81%1.19B | -16.95%178.78M | 11.08%475.14M | -38.23%233.52M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 2.95%1.5B | 22.50%1.45B | -18.42%145.86M | 24.54%591.73M | 51.81%354.5M | 20.83%362.16M | -10.81%1.19B | -16.95%178.78M | 11.08%475.14M | -38.23%233.52M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 2.95%1.5B | 22.50%1.45B | -18.42%145.86M | 24.54%591.73M | 51.81%354.5M | 20.83%362.16M | -10.81%1.19B | -16.95%178.78M | 11.08%475.14M | -38.23%233.52M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 2.88%149.86 | 22.50%145.66 | -18.43%14.61 | 24.54%59.27 | 51.82%35.51 | 20.82%36.27 | -10.81%118.91 | -16.93%17.91 | 11.06%47.59 | -38.22%23.39 |
| Diluted earnings per share | 2.88%149.86 | 22.50%145.66 | -18.42%14.61 | 24.54%59.27 | 51.81%35.5089 | 20.82%36.27 | -10.81%118.91 | -16.94%17.9083 | 11.07%47.59 | -38.22%23.39 |
| Dividend per share | 25.00%25 | 33.33%20 | 33.33%10 | 0 | 33.33%10 | 0 | 0.00%15 | 0.00%7.5 | 0 | 0.00%7.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |